Description

Diaformin (Metformin) Tablets 850 mg – Pack of 60

Composition

Each tablet contains 850 mg of metformin hydrochloride.

Mechanism of Action

Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in the muscles, leading to better utilization of glucose by the body.

Pharmacological Properties

Diaformin exerts its effects by reducing hepatic glucose production and increasing peripheral glucose utilization, thereby lowering blood glucose levels.

Indications for Use

Diaformin tablets are indicated for the treatment of type 2 diabetes mellitus in adults.

Contraindications

Avoid Diaformin if you have severe renal impairment, metabolic acidosis, or a history of hypersensitivity to metformin.

Side Effects

Possible side effects of Diaformin include gastrointestinal disturbances like diarrhea, nausea, and abdominal discomfort. Regular monitoring of blood glucose levels is recommended during treatment.

Usage Instructions

The recommended starting dose is one 850 mg tablet taken orally once daily with food. Dosage adjustments should be made based on individual response and tolerability.

Benefits Compared to Analogues

Diaformin, with its active ingredient metformin, has demonstrated efficacy in improving glycemic control and insulin sensitivity. Studies have also shown long-term benefits in reducing cardiovascular risk factors in patients with type 2 diabetes.

Suitable Patient Groups

Diaformin is suitable for adult patients with type 2 diabetes, including the elderly population. Pediatric use should be determined by a healthcare provider.

Storage and Shelf Life

Store Diaformin tablets in a cool, dry place away from moisture and heat. Check the expiration date on the packaging and do not use the product beyond that date.

Packaging Description

Diaformin tablets are packed in blister packs of 60 tablets each, ensuring convenient and accurate dosing.

Clinical Evidence and Proven Effectiveness

Studies have shown that metformin, the key component of Diaformin, effectively lowers blood glucose levels and enhances insulin sensitivity. Notably, research published in the Journal of Clinical Endocrinology & Metabolism highlighted the cardiovascular risk reduction associated with metformin therapy in patients with type 2 diabetes.

Clinical studies have indicated that metformin treatment is linked to a decreased risk of heart failure compared to other antidiabetic medications. These findings were reported in a study published in Diabetes Care, emphasizing the cardioprotective benefits of metformin.